The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Dihydrofolate Reductase, subunit A
".
FunFam 2: Dihydrofolate reductase
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 26 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Dihydrofolate reductase activity GO:0004146
Catalysis of the reaction: 5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+.
|
13 |
A2BGQ1 (/IDA)
P00374 (/IDA)
P00374 (/IDA)
P00374 (/IDA)
P00374 (/IDA)
P00375 (/IDA)
P00375 (/IDA)
P17719 (/IDA)
P17719 (/IDA)
Q6IQS4 (/IDA)
(3 more) |
Dihydrofolate reductase activity GO:0004146
Catalysis of the reaction: 5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+.
|
13 |
P00374 (/ISS)
P00374 (/ISS)
P00374 (/ISS)
P00374 (/ISS)
P00375 (/ISS)
P00375 (/ISS)
P00376 (/ISS)
P00377 (/ISS)
P00378 (/ISS)
P04753 (/ISS)
(3 more) |
MRNA binding GO:0003729
Interacting selectively and non-covalently with messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
|
9 | P00375 (/ISS) P00375 (/ISS) P00376 (/ISS) P00377 (/ISS) P00378 (/ISS) P04753 (/ISS) P04753 (/ISS) Q920D2 (/ISS) Q920D2 (/ISS) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
9 | P00375 (/ISS) P00375 (/ISS) P00376 (/ISS) P00377 (/ISS) P00378 (/ISS) P04753 (/ISS) P04753 (/ISS) Q920D2 (/ISS) Q920D2 (/ISS) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
6 | B0YJ76 (/IPI) B0YJ76 (/IPI) B0YJ76 (/IPI) B0YJ76 (/IPI) P17719 (/IPI) P17719 (/IPI) |
MRNA binding GO:0003729
Interacting selectively and non-covalently with messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
|
5 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) Q86XF0 (/IDA) |
Translation repressor activity, mRNA regulatory element binding GO:0000900
Antagonizes the ribosome-mediated translation of mRNA into a polypeptide via direct binding (through a selective and non-covalent interaction) to nucleic acid.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
Dihydrofolate reductase activity GO:0004146
Catalysis of the reaction: 5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+.
|
4 | P00374 (/NAS) P00374 (/NAS) P00374 (/NAS) P00374 (/NAS) |
Folic acid binding GO:0005542
Interacting selectively and non-covalently with folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
Methotrexate binding GO:0051870
Interacting selectively and non-covalently with methotrexate, an antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate reductase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
NADPH binding GO:0070402
Interacting selectively and non-covalently with the reduced form, NADPH, of nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
Sequence-specific mRNA binding GO:1990825
Interacting selectively and non-covalently with messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
Dihydrofolate reductase activity GO:0004146
Catalysis of the reaction: 5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+.
|
3 | Q86XF0 (/IMP) Q920D2 (/IMP) Q920D2 (/IMP) |
Translation repressor activity, mRNA regulatory element binding GO:0000900
Antagonizes the ribosome-mediated translation of mRNA into a polypeptide via direct binding (through a selective and non-covalent interaction) to nucleic acid.
|
2 | P00375 (/ISO) P00375 (/ISO) |
MRNA binding GO:0003729
Interacting selectively and non-covalently with messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Dihydrofolate reductase activity GO:0004146
Catalysis of the reaction: 5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Folic acid binding GO:0005542
Interacting selectively and non-covalently with folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Drug binding GO:0008144
Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
|
2 | P00375 (/ISO) P00375 (/ISO) |
NADP binding GO:0050661
Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.
|
2 | Q920D2 (/IDA) Q920D2 (/IDA) |
NADP binding GO:0050661
Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Methotrexate binding GO:0051870
Interacting selectively and non-covalently with methotrexate, an antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate reductase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Dihydrofolic acid binding GO:0051871
Interacting selectively and non-covalently with dihydrofolic acid, a folic acid in which the bicyclic pteridine structure is in the dihydro, partially reduced form; they are intermediates in folate metabolism and are reduced to their tetrahydro, reduced forms.
|
2 | Q920D2 (/IDA) Q920D2 (/IDA) |
Dihydrofolic acid binding GO:0051871
Interacting selectively and non-covalently with dihydrofolic acid, a folic acid in which the bicyclic pteridine structure is in the dihydro, partially reduced form; they are intermediates in folate metabolism and are reduced to their tetrahydro, reduced forms.
|
2 | P00375 (/ISO) P00375 (/ISO) |
NADPH binding GO:0070402
Interacting selectively and non-covalently with the reduced form, NADPH, of nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Sequence-specific mRNA binding GO:1990825
Interacting selectively and non-covalently with messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif.
|
2 | P00375 (/ISO) P00375 (/ISO) |
There are 37 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Tetrahydrofolate metabolic process GO:0046653
The chemical reactions and pathways involving tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.
|
9 | P00375 (/ISS) P00375 (/ISS) P00376 (/ISS) P00377 (/ISS) P00378 (/ISS) P04753 (/ISS) P04753 (/ISS) Q920D2 (/ISS) Q920D2 (/ISS) |
Tetrahydrobiopterin biosynthetic process GO:0006729
The chemical reactions and pathways resulting in the formation of tetrahydrobiopterin, the reduced form of biopterin (2-amino-4-hydroxy-6-(1,2-dihydroxypropyl)-pteridine). It functions as a hydroxylation coenzyme, e.g. in the conversion of phenylalanine to tyrosine.
|
6 | P00374 (/IMP) P00374 (/IMP) P00374 (/IMP) P00374 (/IMP) P00375 (/IMP) P00375 (/IMP) |
Dihydrofolate metabolic process GO:0046452
The chemical reactions and pathways involving dihydrofolate, the dihydroxylated derivative of folate.
|
6 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) Q920D2 (/IDA) Q920D2 (/IDA) |
Tetrahydrofolate biosynthetic process GO:0046654
The chemical reactions and pathways resulting in the formation of tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.
|
6 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) Q920D2 (/IDA) Q920D2 (/IDA) |
Tetrahydrofolate metabolic process GO:0046653
The chemical reactions and pathways involving tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.
|
5 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) Q86XF0 (/IDA) |
Regulation of transcription involved in G1/S transition of mitotic cell cycle GO:0000083
Any process that regulates transcription such that the target genes are involved in the transition between G1 and S phase of the mitotic cell cycle.
|
4 | P00374 (/TAS) P00374 (/TAS) P00374 (/TAS) P00374 (/TAS) |
Tetrahydrobiopterin biosynthetic process GO:0006729
The chemical reactions and pathways resulting in the formation of tetrahydrobiopterin, the reduced form of biopterin (2-amino-4-hydroxy-6-(1,2-dihydroxypropyl)-pteridine). It functions as a hydroxylation coenzyme, e.g. in the conversion of phenylalanine to tyrosine.
|
4 | P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) |
Negative regulation of translation GO:0017148
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
Axon regeneration GO:0031103
The regrowth of axons following their loss or damage.
|
4 | P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) |
Response to methotrexate GO:0031427
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methotrexate stimulus. Methotrexate is 4-amino-10-methylformic acid, a folic acid analogue that is a potent competitive inhibitor of dihydrofolate reductase.
|
4 | P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) |
Folic acid metabolic process GO:0046655
The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
|
4 | P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) |
Folic acid metabolic process GO:0046655
The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
|
4 | P00374 (/TAS) P00374 (/TAS) P00374 (/TAS) P00374 (/TAS) |
Positive regulation of nitric-oxide synthase activity GO:0051000
Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
|
4 | P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) |
Oxidation-reduction process GO:0055114
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
|
4 | P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) P00374 (/IDA) |
Regulation of removal of superoxide radicals GO:2000121
Any process that modulates the frequency, rate or extent of removal of superoxide radicals.
|
4 | P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) P00374 (/ISS) |
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
|
3 | A2BGQ1 (/IMP) Q6IQS4 (/IMP) Q98TR9 (/IMP) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
3 | A2BGQ1 (/IGI) Q6IQS4 (/IGI) Q98TR9 (/IGI) |
Bulbus arteriosus development GO:0003232
The process whose specific outcome is the progression of the bulbus arteriosus over time, from its formation to the mature structure. The bulbus arteriosus is an elastic heart chamber.
|
3 | A2BGQ1 (/IMP) Q6IQS4 (/IMP) Q98TR9 (/IMP) |
Folic acid metabolic process GO:0046655
The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
|
3 | A2BGQ1 (/IMP) Q6IQS4 (/IMP) Q98TR9 (/IMP) |
Embryonic morphogenesis GO:0048598
The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
|
3 | A2BGQ1 (/IMP) Q6IQS4 (/IMP) Q98TR9 (/IMP) |
Heart contraction GO:0060047
The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
|
3 | A2BGQ1 (/IMP) Q6IQS4 (/IMP) Q98TR9 (/IMP) |
Tetrahydrobiopterin biosynthetic process GO:0006729
The chemical reactions and pathways resulting in the formation of tetrahydrobiopterin, the reduced form of biopterin (2-amino-4-hydroxy-6-(1,2-dihydroxypropyl)-pteridine). It functions as a hydroxylation coenzyme, e.g. in the conversion of phenylalanine to tyrosine.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Negative regulation of translation GO:0017148
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Axon regeneration GO:0031103
The regrowth of axons following their loss or damage.
|
2 | Q920D2 (/IMP) Q920D2 (/IMP) |
Axon regeneration GO:0031103
The regrowth of axons following their loss or damage.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Response to methotrexate GO:0031427
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methotrexate stimulus. Methotrexate is 4-amino-10-methylformic acid, a folic acid analogue that is a potent competitive inhibitor of dihydrofolate reductase.
|
2 | Q920D2 (/IDA) Q920D2 (/IDA) |
Response to methotrexate GO:0031427
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methotrexate stimulus. Methotrexate is 4-amino-10-methylformic acid, a folic acid analogue that is a potent competitive inhibitor of dihydrofolate reductase.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Response to nicotine GO:0035094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
2 | Q920D2 (/IEP) Q920D2 (/IEP) |
Dihydrofolate metabolic process GO:0046452
The chemical reactions and pathways involving dihydrofolate, the dihydroxylated derivative of folate.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Tetrahydrofolate metabolic process GO:0046653
The chemical reactions and pathways involving tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Tetrahydrofolate biosynthetic process GO:0046654
The chemical reactions and pathways resulting in the formation of tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Folic acid metabolic process GO:0046655
The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
|
2 | Q920D2 (/IDA) Q920D2 (/IDA) |
Folic acid metabolic process GO:0046655
The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Positive regulation of nitric-oxide synthase activity GO:0051000
Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
|
2 | P00375 (/IMP) P00375 (/IMP) |
Oxidation-reduction process GO:0055114
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Regulation of removal of superoxide radicals GO:2000121
Any process that modulates the frequency, rate or extent of removal of superoxide radicals.
|
2 | P00375 (/IMP) P00375 (/IMP) |
Thymidine biosynthetic process GO:0046105
The chemical reactions and pathways resulting in the formation of thymidine, deoxyribosylthymine thymine 2-deoxyriboside, a deoxynucleoside very widely distributed but occurring almost entirely as phosphoric esters in deoxynucleotides and deoxyribonucleic acid, DNA.
|
1 | Q86XF0 (/IDA) |
There are 9 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
13 |
B0YJ76 (/IDA)
B0YJ76 (/IDA)
B0YJ76 (/IDA)
B0YJ76 (/IDA)
P00374 (/IDA)
P00374 (/IDA)
P00374 (/IDA)
P00374 (/IDA)
P00375 (/IDA)
P00375 (/IDA)
(3 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
6 | P00374 (/TAS) P00374 (/TAS) P00374 (/TAS) P00374 (/TAS) P00375 (/TAS) P00375 (/TAS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
4 | P00375 (/IDA) P00375 (/IDA) Q920D2 (/IDA) Q920D2 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
4 | P00376 (/ISS) P00377 (/ISS) P04753 (/ISS) P04753 (/ISS) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
4 | P00376 (/ISS) P00377 (/ISS) P04753 (/ISS) P04753 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | P00375 (/ISO) P00375 (/ISO) |
Mitochondrial inner membrane GO:0005743
The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.
|
1 | Q86XF0 (/IMP) |
Mitochondrial matrix GO:0005759
The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.
|
1 | Q86XF0 (/IMP) |